FlexBot Gait Rehabilitation Robot

FlexBot serves as QianJing’s primary robot-assisted gait rehabilitation platform, designed to support lower limb training for patients recovering from stroke, spinal cord injuries, and other neurological conditions. The system combines robotic assistance with therapeutic protocols to support motor recovery and walking function restoration in clinical rehabilitation settings.

Product Overview

Developed by Changzhou Qianjing Rehabilitation Co., Ltd., FlexBot represents the company’s entry into the robot-assisted therapy (R-aT) segment of the rehabilitation market. The system addresses the growing demand for technology-enhanced gait training in Chinese hospitals and rehabilitation centers, where manual therapy alone often proves insufficient for intensive lower limb rehabilitation programs.

FlexBot integrates with QianJing’s broader rehabilitation equipment ecosystem, allowing facilities to combine robotic gait training with the company’s physical therapy beds, strength trainers, and assessment tools. This integration supports full rehabilitation programs that progress patients from acute care through functional recovery.

Key Features

At the core of QianJing’s gait rehabilitation lineup, FlexBot combines motorized lower-limb assistance, body-weight support, and adjustable training parameters for post-stroke and spinal cord injury patients.

• Robotic Gait Assistance: Provides motorized support for lower limb movement patterns during walking exercises
• Adjustable Training Parameters: Allows therapists to modify assistance levels, speed, and range of motion based on patient capabilities
• Body Weight Support: Integrated suspension system reduces load on patient joints during training
• Safety Mechanisms: Multiple protective features to prevent falls and accommodate sudden changes in patient condition
• Progress Monitoring: Data collection capabilities for tracking rehabilitation outcomes over time

Technical Specifications

FlexBot-S is a fixed-type indoor/outdoor gait trainer certified to ISO and RoHS; motor power, speed range, and weight capacity should be confirmed directly with QianJing.

Note: Detailed technical specifications including motor power, speed range, and weight capacity are not publicly documented. Facilities should contact QianJing directly for full technical data.

Clinical Applications

FlexBot targets patients requiring intensive gait rehabilitation, particularly those with:

• Post-stroke motor impairment affecting walking ability
• Incomplete spinal cord injuries with preserved lower limb function
• Traumatic brain injury resulting in gait abnormalities
• Progressive neurological conditions requiring mobility maintenance
• Orthopedic conditions requiring protected weight-bearing exercise

The system supports both inpatient rehabilitation programs in hospitals and outpatient therapy at dedicated rehabilitation centers. Training protocols can be adapted for patients at various recovery stages, from early mobilization to advanced community ambulation preparation.

Regulatory Status

QianJing’s rehabilitation products are commercially available in China and exported to international markets including the United States, United Kingdom, Germany, and Japan. Specific regulatory approval dates for FlexBot are not publicly documented; facilities should verify current certification status directly with the manufacturer.

Market Context

FlexBot competes in China’s expanding rehabilitation robot market, which has seen significant growth driven by aging demographics and increased healthcare investment in rehabilitation services. While international systems like Hocoma’s Lokomat have established presence in top-tier Chinese hospitals, domestic alternatives like FlexBot offer potential cost advantages for mid-tier facilities seeking to add robotic capabilities.

QianJing’s established distribution network across 20,000+ institutional users provides FlexBot with market access that newer competitors may lack. The company’s broad product portfolio also enables bundled offerings combining robotic systems with traditional rehabilitation equipment.

Frequently Asked Questions

What conditions can FlexBot treat?

FlexBot is designed for gait rehabilitation in patients with stroke, spinal cord injuries, traumatic brain injuries, and other neurological conditions affecting walking ability. The system provides robotic assistance during walking exercises to help restore motor function and improve mobility outcomes.

How does FlexBot compare to imported gait training robots?

FlexBot offers a domestically manufactured alternative to imported systems like Lokomat. While specific performance comparisons are not publicly available, domestic systems typically provide cost advantages and local service support. Facilities should request demonstration sessions and clinical outcome data from QianJing for direct comparison with imported alternatives.

Is FlexBot suitable for home use?

FlexBot is designed for institutional use in hospitals, rehabilitation centers, and clinical facilities. The system requires trained therapist supervision and clinical infrastructure not typically available in home settings. QianJing offers separate products for home-based rehabilitation needs.